Kaiva Strategies, LLC

Ivins, UT Part of Kaiva Tech, LLC

UEI
HCWKVFGBPA64
CAGE
99AZ4
Primary NAICS
541511 Custom Computer Programming Services
SAM.gov registration
Active through

Company facts

SBA certifications
8(a) Joint Venture
– · Ended
Self-certified in SAM.gov
  • Tribally Owned Firm
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Small Business Joint Venture
  • Self-Certified HUBZone Joint Venture
  • Limited Liability Company
  • Native American Owned
Entity structure
Other
Corporate family
SAM.gov registration date
Physical address
6060 W 3650 N #1000, Ivins, UT 84738, USA
Website
kaivacorp.com
Founded
2007
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
  4. Consulting
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $47,245,221
FY2025 $46,021,002
FY2024 $27,501,225
FY2023 $11,085,258

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Health and Human Services $47,245,221

Contract vehicles

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Kaiva Strategies, LLC is a tribally-owned, minority-owned 8(a) joint venture based in Ivins, Utah, that delivers professional, administrative, and consulting services to the Food and Drug Administration as a prime contractor under competitive 8(a) and 8(a) sole-source set-asides, with recent expansion into CDC help desk support and GSA Schedule staffing. The company operates as a managed service delivery vehicle, subcontracting approximately 74 percent of contractor hours across its SCI-reportable prime contracts to a deep bench of specialized labor partners and maintaining an 8(a) Business Development Program certification expiring August 2025.

Kaiva Strategies' federal footprint is heavily concentrated in FDA work. Of 79 total awards in the recent source window, 76 awards worth $278.2 million in combined potential value flow to FDA; the remaining portfolio includes two CDC Pittsburgh awards ($35 million combined) and a single GSA Federal Acquisition Service Schedule contract ($10 million ceiling). The vendor's activity has grown significantly, from four awards in 2022 to 23 in 2026 year-to-date. Within 24 months, 25 awards carrying $103.2 million in combined potential value reach ultimate completion, creating recompete exposure across the portfolio.

Kaiva Strategies holds two major FDA indefinite-delivery contracts that anchor its prime business: a $100 million competitive 8(a) Professional, Administrative, and Consulting Services (PACS) IDIQ (ultimate completion August 2028) and a $22 million 8(a) sole-source medical writing support IDIQ (ultimate completion June 2027). The PACS vehicle has generated 39 task orders worth $106.7 million in combined potential value; the medical writing IDIQ has generated 9 task orders worth $17.1 million. Representative recent delivery orders under PACS include a $32.7 million labor-hour task order for budget and acquisition liaison support to FDA's Office of Finance, Budget, and Acquisitions (September 2026), an $8.8 million labor-hour task order for medical writer support to the Center for Biologics Evaluation and Research (September 2026), a $13 million labor-hour task order for health science support to the Center for Drug Evaluation and Research Office of New Drugs (June 2025), and a $3.6 million labor-hour task order for logistics and supply chain support to the Center for Devices and Radiological Health (July 2025). Work spans senior executive public speaking training, drug compounding coordination, regulatory review, position classification support, export certification program support, medical writing, scientific editing, budget and acquisition liaison functions, and health science consulting across FDA centers and offices.

Under Service Contract Inventory reporting, Kaiva Strategies invoiced $36.1 million across the past three fiscal years, rising from $3.4 million in FY2023 to $7.6 million in FY2024 to $25.1 million in FY2025, reflecting substantial year-over-year growth. SCI-reported FTE headcount reached 74.8 FTEs in FY2025 (drawn from 37 prime contracts), up from 39.5 FTEs in FY2024. Government-paid hourly rates across the portfolio median around $112.81 per hour, with rates ranging from $77.11 per hour at the 10th percentile (entry-level help desk and administrative support) to $315.84 per hour at the 90th percentile (PhD-level subject matter experts and specialized regulatory consultants). Across 76 named subcontractors reported in SCI records, Kaiva subcontracts 74 percent of contractor hours on average, consistent with its operating model as a managed service delivery vehicle that leverages specialized labor partners rather than building out internal staff.

Beyond the FDA IDIQs, Kaiva Strategies holds a $6 million definitive contract with CDC Pittsburgh for help desk and user support services (ultimate completion August 2029; $1.1 million invoiced in FY2025 across 6.3 FTEs and 13,160 hours at $86.17 per hour) and a $29 million definitive time-and-materials contract with CDC Pittsburgh for public health infrastructure support (ultimate completion January 2027; $9.1 million invoiced in FY2025 across 20.3 FTEs and 42,168 hours at $215.09 per hour), indicating penetration beyond FDA into public health agency work. Kaiva Strategies also holds a $10 million GSA Federal Acquisition Service Multiple Award Schedule contract (October 2025 award, performance through October 2030) spanning 80 labor categories from help desk specialist roles at $70.36 per hour through PhD-level subject matter experts at $311.86 per hour, with no security-cleared positions offered; the schedule reflects staffing and consulting delivery capability across federal civilian agencies.

Kaiva Strategies' parent entity is Kaiva Tech, LLC, also tribally-owned, minority-owned, and 8(a)-certified (through March 2030), which holds its own federal contract prime awards and shares the same headquarters address in Ivins, Utah.

SBA capabilities narrative

Kaiva Strategies is an SBA certified 8(a) and HUBZone Joint Venture between Kaiva Tech, LLC and DRT Strategies, Inc., who share a combined mission to deliver multi-disciplined expertise in science, health, technology and professional consulting services to solve complex problems.

Quick answers

Is Kaiva Strategies, LLC registered in SAM.gov?

Yes. Kaiva Strategies, LLC's SAM.gov registration is active through July 28, 2027.

Which contract vehicles does Kaiva Strategies, LLC hold?

Kaiva Strategies, LLC holds a place on 1 federal contract vehicle: MAS.

How much has Kaiva Strategies, LLC received in federal contracts?

Federal contracts obligated $46,021,002 to Kaiva Strategies, LLC in fiscal year 2025 and $131,852,705 in fiscal years 2023 through 2027.

How does Kaiva Strategies, LLC rank among federal contractors?

Kaiva Strategies, LLC ranked #22 in PSC R406, #26 in PSC R610 and #39 in NAICS 541611 in FY2025.

What is Kaiva Strategies, LLC's most recent federal award?

Kaiva Strategies, LLC's most recent federal contract award is 2-year (base year & 1 option year), firm fixed price (FFP) task order for senior executive public speaking training… (75F40126F19041), from Food and Drug Administration, on September 30, 2026.

On GovTribe

See Kaiva Strategies, LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors